Natco Pharma
quarterly
yearly
| Particulars | Jun '21 | Sep '21 | Dec '21 | Mar '22 | Jun '22 |
|---|---|---|---|---|---|
| Revenue | 410.30 | 377.20 | 560.50 | 596.80 | 884.60 |
| Expenses | 334.30 | 341.40 | 494.70 | 653.50 | 528.90 |
| EBITDA | 76.00 | 35.80 | 65.80 | -56.70 | 355.70 |
| EBIT | 42.20 | 1.10 | 29.80 | -94.80 | 316.10 |
| Profit Before Tax | 91.00 | 69.80 | 91.00 | -49.60 | 385.80 |
| Net Profit | 75.00 | 65.10 | 80.40 | -50.50 | 320.40 |
| Financial Ratios | |||||
| Operating Profit Margin | 18.52% | 9.49% | 11.74% | -9.50% | 40.21% |
| Net Profit Margin | 18.28% | 17.26% | 14.34% | -8.46% | 36.22% |
| Earning Per Share (Diluted) | 4.11 | 3.57 | 4.40 | -2.77 | 17.55 |
| Dividends Per Share | 2.00 | 0.50 | 2.00 | NA | 3.50 |
